Published in Ann Oncol on March 15, 2007
Central nervous system recurrence of systemic lymphoma in the era of stem cell transplantation--an International Primary Central Nervous System Lymphoma Study Group project. Haematologica (2012) 0.93
A multicentre retrospective comparison of central nervous system prophylaxis strategies among patients with high-risk diffuse large B-cell lymphoma. Br J Cancer (2014) 0.89
Central nervous system prophylaxis with intrathecal liposomal cytarabine in a subset of high-risk patients with diffuse large B-cell lymphoma receiving first line systemic therapy in a prospective trial. Ann Hematol (2016) 0.78
Highly elevated serum lactate dehydrogenase is associated with central nervous system relapse in patients with diffuse large B-cell lymphoma: Results of a multicenter prospective cohort study. Oncotarget (2016) 0.75
Prediction of Central Nervous System Relapse of Diffuse Large B-Cell Lymphoma Using Pretherapeutic [18F]2-Fluoro-2-Deoxyglucose (FDG) Positron Emission Tomography/Computed Tomography. Medicine (Baltimore) (2015) 0.75
Stromal gene signatures in large-B-cell lymphomas. N Engl J Med (2008) 11.34
Complete sequence of the staphylococcal gene encoding protein A. A gene evolved through multiple duplications. J Biol Chem (1984) 5.94
Prostate cancer and supplementation with alpha-tocopherol and beta-carotene: incidence and mortality in a controlled trial. J Natl Cancer Inst (1998) 4.72
HABITS (hormonal replacement therapy after breast cancer--is it safe?), a randomised comparison: trial stopped. Lancet (2004) 4.40
Current status of clinical islet transplantation. Transplantation (2005) 4.17
Prospective randomized trial comparing mitomycin, cisplatin, and protracted venous-infusion fluorouracil (PVI 5-FU) With epirubicin, cisplatin, and PVI 5-FU in advanced esophagogastric cancer. J Clin Oncol (2002) 3.98
A monoclonal antibody-defined antigen associated with gastrointestinal cancer is a ganglioside containing sialylated lacto-N-fucopentaose II. J Biol Chem (1982) 3.97
A reproducible grading scale for histological assessment of inflammation in ulcerative colitis. Gut (2000) 3.69
Patient satisfaction after anaesthesia and surgery: results of a prospective survey of 10,811 patients. Br J Anaesth (2000) 3.46
Diagnostic guidelines for hemophagocytic lymphohistiocytosis. The FHL Study Group of the Histiocyte Society. Semin Oncol (1991) 3.15
Region X, the cell-wall-attachment part of staphylococcal protein A. Eur J Biochem (1984) 3.00
Immobilization and purification of enzymes with staphylococcal protein A gene fusion vectors. EMBO J (1985) 2.91
Oligosaccharides on proteoglycans from the swarm rat chondrosarcoma. J Biol Chem (1980) 2.89
Single breath diffusing capacity in a representative sample of the population of Michigan, a large industrial state. Predicted values, lower limits of normal, and frequencies of abnormality by smoking history. Am Rev Respir Dis (1983) 2.83
Cloning and expression of the gene for a fibronectin-binding protein from Staphylococcus aureus. EMBO J (1987) 2.79
Production of tissue factor by pancreatic islet cells as a trigger of detrimental thrombotic reactions in clinical islet transplantation. Lancet (2002) 2.76
An improved positive selection plasmid vector constructed by oligonucleotide mediated mutagenesis. Nucleic Acids Res (1983) 2.69
Cardiotocography only versus cardiotocography plus ST analysis of fetal electrocardiogram for intrapartum fetal monitoring: a Swedish randomised controlled trial. Lancet (2001) 2.68
High-level production of uniformly ¹⁵N- and ¹³C-enriched fusion proteins in Escherichia coli. J Biomol NMR (1996) 2.38
Cytomegalovirus infection of human blood cells. J Infect Dis (1984) 2.38
Surgical margins, local recurrence and metastasis in soft tissue sarcomas: 559 surgically-treated patients from the Scandinavian Sarcoma Group Register. Eur J Cancer (2000) 2.34
Incidence in Sweden and clinical features of familial hemophagocytic lymphohistiocytosis. Acta Paediatr Scand (1991) 2.29
The influence of age on apoptotic and other mechanisms of cell death after cerebral hypoxia-ischemia. Cell Death Differ (2005) 2.22
Pretreatment prognostic factors and scoring system in 407 small-cell lung cancer patients. Int J Cancer (1987) 2.18
Randomized phase II study of two gemcitabine schedules for patients with impaired performance status (Karnofsky performance status </= 70) and advanced non-small-cell lung cancer. J Clin Oncol (2005) 2.17
Truncated GLP-1 (proglucagon 78-107-amide) inhibits gastric and pancreatic functions in man. Dig Dis Sci (1993) 2.16
5-HT3 receptor antagonists in the prophylaxis of acute vomiting induced by moderately emetogenic chemotherapy--a randomised study. Eur J Cancer (1993) 2.15
EUS-guided FNA immediately after unrevealing transbronchial needle aspiration in the evaluation of mediastinal lymphadenopathy: a prospective study. Gastrointest Endosc (2006) 2.15
Histone H3 phosphorylation and expression of cyclins A and B1 measured in individual cells during their progression through G2 and mitosis. Cytometry (1998) 2.11
Histopathological risk factors for ipsilateral breast events after breast conserving treatment for ductal carcinoma in situ of the breast--results from the Swedish randomised trial. Eur J Cancer (2006) 2.09
Prevalence of disease among vinyl chloride and polyvinyl chloride workers. Ann N Y Acad Sci (1975) 2.04
[Treatment with growth factors and cytokines in hematologic diseases]. Tidsskr Nor Laegeforen (1996) 2.03
Bacterial endotoxin sensitizes the immature brain to hypoxic--ischaemic injury. Eur J Neurosci (2001) 2.02
Cerebral palsy and restricted growth status at birth: population-based case-control study. BJOG (2008) 1.90
Risk of cancer among offspring of childhood-cancer survivors. Association of the Nordic Cancer Registries and the Nordic Society of Paediatric Haematology and Oncology. N Engl J Med (1998) 1.87
Cancer surveillance of patients with longstanding ulcerative colitis: a clinical, endoscopical, and histological study. Gut (1986) 1.87
Proteoglycans of developing bone. J Biol Chem (1983) 1.86
Damage to porcine islets of Langerhans after exposure to human blood in vitro, or after intraportal transplantation to cynomologus monkeys: protective effects of sCR1 and heparin. Transplantation (2000) 1.83
Blue babies and nitrate-contaminated well water. Environ Health Perspect (2000) 1.82
Psoriasis patients with antibodies to gliadin can be improved by a gluten-free diet. Br J Dermatol (2000) 1.82
Nationwide cerebrovascular disease morbidity study. Stroke (1972) 1.82
Synergistic activation of caspase-3 by m-calpain after neonatal hypoxia-ischemia: a mechanism of "pathological apoptosis"? J Biol Chem (2000) 1.77
Apoptosis-inducing factor is a major contributor to neuronal loss induced by neonatal cerebral hypoxia-ischemia. Cell Death Differ (2006) 1.77
Effects of supplemental alpha-tocopherol and beta-carotene on colorectal cancer: results from a controlled trial (Finland) Cancer Causes Control (2000) 1.75
Isolated human islets trigger an instant blood mediated inflammatory reaction: implications for intraportal islet transplantation as a treatment for patients with type 1 diabetes. Ups J Med Sci (2000) 1.74
Analysis of signals for secretion in the staphylococcal protein A gene. EMBO J (1985) 1.72
Humoral immunity to viral and bacterial antigens in lymphoma patients 4-10 years after high-dose therapy with ABMT. Serological responses to revaccinations according to EBMT guidelines. Bone Marrow Transplant (2001) 1.66
Response after withdrawal of tamoxifen and progestogens in advanced breast cancer. Ann Oncol (1992) 1.65
Incompatibility between human blood and isolated islets of Langerhans: a finding with implications for clinical intraportal islet transplantation? Diabetes (1999) 1.65
Alpha-2b interferon and oral clodronate for Gorham's disease. Lancet (1998) 1.63
Shoulder pain in middle age. A study of prevalence and relation to occupational work load and psychosocial factors. Clin Orthop Relat Res (1988) 1.62
Health-related quality of life measured by the EORTC QLQ-C30--reference values from a large sample of Swedish population. Acta Oncol (2000) 1.62
Expression of the gene encoding protein A in Staphylococcus aureus and coagulase-negative staphylococci. J Bacteriol (1984) 1.61
Clinical factors associated with the non-utilization of an anaesthesia incident reporting system. Br J Anaesth (2011) 1.61
Gene fusion vectors based on the gene for staphylococcal protein A. Gene (1983) 1.61
Meteorological influence on aerosol extinction in the 0.2-40-microm wavelength range. Appl Opt (1979) 1.61
A randomized comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patients. Br J Haematol (1997) 1.59
Musculoskeletal disorders among visual display terminal workers: individual, ergonomic, and work organizational factors. Ergonomics (1995) 1.58
Staphylococcal protein A consists of five IgG-binding domains. Eur J Biochem (1986) 1.56
Enhanced local production of complement components in the small intestines of patients with Crohn's disease. N Engl J Med (1990) 1.56
Morphological changes and apoptosis in bone marrow from patients with myelodysplastic syndromes treated with granulocyte-CSF and erythropoietin. Leuk Res (1997) 1.55
A randomised placebo controlled study with ondansetron in patients undergoing fractionated radiotherapy. Ann Oncol (1996) 1.54
Down-regulation of interferon-gamma parallels clinical response to selective leukocyte apheresis in patients with inflammatory bowel disease: a 12-month follow-up study. Int J Colorectal Dis (2006) 1.53
Relation between drug treatment and cancer in hypertensives in the Swedish Trial in Old Patients with Hypertension 2: a 5-year, prospective, randomised, controlled trial. Lancet (2001) 1.52
Increased cancer risk in offspring of women with colorectal carcinoma: a Swedish register-based cohort study. Cancer (2000) 1.52
High-resolution solution NMR structure of the Z domain of staphylococcal protein A. J Mol Biol (1997) 1.52
Carcinoma of the parotid and submandibular glands--a study of survival in 2465 patients. Oral Oncol (2002) 1.51
A high pretreatment serum vascular endothelial growth factor concentration is associated with poor outcome in non-Hodgkin's lymphoma. Blood (1997) 1.51
Occupational exposure to electromagnetic fields in relation to leukemia and brain tumors: a case-control study in Sweden. Cancer Causes Control (1993) 1.51
Prediction of spontaneous preterm delivery in women with threatened preterm labour: a prospective cohort study of multiple proteins in maternal serum. BJOG (2012) 1.51
Receptor-specific agglutination tests for detection of bacteria that bind globoseries glycolipids. J Clin Microbiol (1987) 1.47
Venereal transmission of shigellosis in Seattle-King county. Sex Transm Dis (1978) 1.47
Clinical stage I and II Hodgkin's disease: long-term results of therapy without laparotomy. Experience at one institution. Ann Oncol (1996) 1.45
Multicenter evaluation of the Micral-Test II test strip, an immunologic rapid test for the detection of microalbuminuria. Diabetes Care (1997) 1.45
Neoadjuvant, adjuvant and palliative treatment of gastrointestinal stromal tumours (GIST) with imatinib: a centre-based study of 17 patients. Br J Cancer (2003) 1.44
Elevated serum levels of soluble ICAM-1 in non-Hodgkin's lymphomas correlate with tumour burden, disease activity and other prognostic markers. Br J Haematol (1996) 1.44
Persistent changes in the immune system 4-10 years after ABMT. Bone Marrow Transplant (1999) 1.44
Colonoscopic surveillance in long-standing total ulcerative colitis--a 15-year follow-up study. Gastroenterology (1990) 1.43
Myelodysplastic syndrome following epipodophyllotoxin therapy in familial hemophagocytic lymphohistiocytosis. Pediatr Hematol Oncol (1993) 1.43
The significance of ulcer disease on late mortality after partial gastric resection. Eur J Gastroenterol Hepatol (1997) 1.43
A gene fusion system for generating antibodies against short peptides. Gene (1987) 1.42
Structural studies on the carbohydrate portion of fetuin. J Biol Chem (1979) 1.41
Protective effects of moderate hypothermia after neonatal hypoxia-ischemia: short- and long-term outcome. Pediatr Res (1998) 1.41
The decision of the Karolinska Institute following an independent investigation of the research carried out by Associate Professor Ulf Lönn. Breast Cancer Res Treat (1998) 1.40
Antibodies to Lyme-disease spirochaete in European lymphocytic meningoradiculitis (Bannwarth's syndrome) Lancet (1983) 1.39
[High-dose autologous stem cell support in malignant diseases--an established method, uncertain indication]. Tidsskr Nor Laegeforen (1994) 1.39
Fine needle aspiration biopsy of hepatocellular carcinoma. Some unusual features. Acta Cytol (1991) 1.38
Never on a Saturday (or a Sunday): the case against using weekend urine specimens to assess arsenic exposure. WMJ (1998) 1.38
The role of postoperative alkylating agent therapy in early-stage epithelial ovarian cancer. Br J Obstet Gynaecol (1989) 1.38
Central nervous system involvement following diagnosis of non-Hodgkin's lymphoma: a risk model. Ann Oncol (2002) 1.37
The risk of colorectal cancer in ulcerative colitis. An epidemiologic study. Scand J Gastroenterol (1987) 1.37
Positron emission tomography in clinical islet transplantation. Am J Transplant (2009) 1.37
Reversed-phase high-performance liquid chromatography: preparative purification of synthetic peptides. J Chromatogr (1984) 1.37